Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 701–800 of 911
Molecular mechanisms regulating telomerase activity
Liu, J. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)08003-8 · Cited by 11
Cell Senescence and the Genetics of Melanoma Development
Constantinou, S. M., & Bennett, D. C. (2024) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23273 · Cited by 8
Swanberg, S. E., & Delany, M. E. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50030-8 · Cited by 9
There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer
Kirkpatrick, K. L., Newbold, R. F., & Mokbel, K. (2004) · International Seminars in Surgical Oncology · doi:10.1186/1477-7800-1-2 · Cited by 8
Fathi, E., Farahzadi, R., Rahbarghazi, R., Kafil, H. S., & Yolmeh, R. (2017) · PubMed Central · Cited by 11
Telomere maintenance mechanisms in neuroblastoma: New insights and translational implications
Werr, L., Rosswog, C., Bartenhagen, C., George, S. L., & Fischer, M. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100156 · Cited by 8
Aging and Carcinogenesis – Insufficient Metabolic Cell Repair as the Common Link
Baramiya, M. G. (2000) · Gerontology · doi:10.1159/000022186 · Cited by 8
Immortalization of bovine germ line stem cells by c-myc and hTERT
Bi, C.-M., Zhang, S., Zhang, Y., Peng, S., Wang, L., An, Z., Qi, A., & Lv, N. (2006) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2006.10.017 · Cited by 8
Je, K.-H., Kim, K. N., Nam, K., Cho, M., & Mar, W. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977804 · Cited by 8
Eitsuka, T., Nakagawa, K., Ono, Y., Tatewaki, N., Nishida, H., KURATA, T., Shoji, N., & Miyazawa, T. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.027 · Cited by 8
D’Agnano, I., Valentini, A., Gatti, G., Chersi, A., & Felsani, A. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20810 · Cited by 8
Ml, A., Severin, E. S., & Glukhov, A. I. (2003) · Biochemistry (Moscow) · doi:10.1023/b:biry.0000011648.51641.04 · Cited by 8
Cheng, W., Wei, Z., Gao, J., Zhang, Z., Ge, J., Jing, K.-Z., Xu, F., & Xie, P. (2010) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-010-0363-2 · Cited by 7
Deezagi, A., Manteghi, S., Khosravani, P., Vaseli-Hagh, N., & Soheili, Z. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190903129130 · Cited by 7
Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer
Zhang, W., Veisaga, M. L., & Barbieri, M. A. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112318 · Cited by 8
Ballon, G., Trentin, L., Rossi, A. D., & Semenzato, G. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057952 · Cited by 8
Akiyama, M., Yamada, O., Yanagisawa, T., Fujisawa, K., Eto, Y., & Yamada, H. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20392 · Cited by 7
Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation
Vardaka, P., Kemp, B., Stephenson, S., Stephenson, S., Care, M. A., Umpierrez, M., O'Callaghan, E., O’Callaghan, E., Owen, R. G., Hodson, D. J., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202402814 · Cited by 6
Liu, Q., Nguyen, É., Døskeland, S. O., & Ségal-Bendirdjian, É. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.097915 · Cited by 6
Tran, D. A., Wong, T. C., Schep, A. N., & Drewell, R. A. (2010) · DNA and Cell Biology · doi:10.1089/dna.2009.0994 · Cited by 6
Regulation of Telomerase Activity
Nalobin, D. S., Galiakberova, A. A., Alipkina, S. I., & Glukhov, A. I. (2018) · Biology Bulletin Reviews · doi:10.1134/s2079086418020068 · Cited by 6
Telomeres and Telomerase Regulation
Lansdorp, P. M. (2004) · Elsevier eBooks · doi:10.1016/b978-012436643-5/50101-2 · Cited by 6
The Role of Telomeres in Liver Disease
Sunami, Y., von Figura, G., Kleger, A., Strnad, P., Hüser, N., & Hartmann, D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00007-4 · Cited by 5
The Presence of Dioxin in Kidney Cells Induces Cell Death with Autophagy
Fiorito, F., & Martino, L. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-405530-8.00011-x · Cited by 5
Randhawa, V., & Kumar, M. (2021) · Molecular Omics · doi:10.1039/d1mo00199j · Cited by 5
Cucurbitacins: Nature’s Wonder Molecules
Kanani, S. H., & Pandya, D. J. (2022) · Current Traditional Medicine · doi:10.2174/2215083808666220107104220 · Cited by 6
Boroujeni, A. M., Yousefi, E., Gupta, S., Benayed, R., Berger, M. F., Ladanyi, M., Monroe, R., Kim, J., Jungbluth, A. A., Weigelt, B., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153892 · Cited by 7
Liu, J., Zhao, S., Li, Z., Zhang, Z., Zhao, B., Guan, G., Yin, H., & Luo, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1128433 · Cited by 5
Cancer: Is There Involved a Bunch of Culprits, One Culprit, or Something in Between?
Svoboda, J. (2000) · Folia Biologica · doi:10.14712/fb2000046060219 · Cited by 5
E4F1 and ZNF148 are transcriptional activators of the −57A > C and wild-type TERT promoter
Chua, B. H., Anuar, N. Z., Ferry, L., Domrane, C., Wittek, A., Mukundan, V. T., Jha, S., Butter, F., Tenen, D. G., Defossez, P., et al. (2023) · Genome Research · doi:10.1101/gr.277724.123 · Cited by 5
Biogenesis and Regulation of Telomerase during Development and Cancer
Chen, L., & Batista, L. F. Z. (2025) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041692 · Cited by 6
Pathology of peripheral neuroblastic tumors
Conces, M. R., Shibui, Y., & Shimada, H. (2026) · Diagnostic Pathology · doi:10.1186/s13000-026-01758-y · Cited by 4
Ribrag, V., & Bosq, J. (2002) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(02)00044-4 · Cited by 4
Jarzembowski, J. A., Navarro, S., & Shimada, H. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04083-9 · Cited by 4
Masoudi, E., Soleimani, M., Zarinfard, G., Homayoun, M., & Bakhtiari, M. (2024) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.394820 · Cited by 4
Portillo, A. M., García-Velasco, J. A., & Varela, E. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109305 · Cited by 4
Goldberg-Bittman, L., Kitay‐Cohen, Y., Fejgin, M. D., Hadary, R., Quitt, M., & Amiel, A. (2009) · Cancer Investigation · doi:10.3109/07357900903095748 · Cited by 5
Telomeres and Telomerase in Neuroblastoma
Hajj, J. E., Garsuault, D., Bouyer, C., Nguyen, É., Hilal, G., & Ségal-Bendirdjian, E. (2017) · InTech eBooks · doi:10.5772/intechopen.69567 · Cited by 5
Jansons, J., Олеговна, Б. Е., Skrastiņa, D., Kurlanda, A., Fridrihsone, I., Kostyushev, D. S., Kostyusheva, A. P., Artyuhov, A., Dashinimaev, E. B., Avdoshina, D., et al. (2020) · Vaccines · doi:10.3390/vaccines8020318 · Cited by 4
Jenkhetkan, W., Itharat, A., Kongkham, S., Ruangnoo, S., & Ratanavalachai, T. (2021) · Trends in Sciences · doi:10.48048/tis.2021.409 · Cited by 4
Pathomechanisms of Endogenously Aged Skin
Makrantonaki, E., & Zouboulis, C. C. (2009) · Springer eBooks · doi:10.1007/978-3-540-89656-2_9 · Cited by 5
Shedding Light on the Interaction Between Rif1 and Telomeres in Ovarian Cancer
Kordowitzki, P., Graczyk, S., Mechsner, S., & Sehouli, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0716 · Cited by 4
Isogenic human mammary epithelial cell lines: novel tools for target identification and validation
Ulbricht, U., Sommer, A., Beckmann, G., Lutzenberger, M., Seidel, H., Kreft, B., & Toschi, L. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2472-7 · Cited by 4
Pathomechanisms of Endogenously Aged Skin
Makrantonaki, E., & Zouboulis, C. C. (2015) · Springer eBooks · doi:10.1007/978-3-642-27814-3_9-2 · Cited by 4
Telomerase and Cancer: A Promising Target
Falchetti, M. L., Pallini, R., & Levi, A. (2004) · American Journal of Cancer · doi:10.2165/00024669-200403010-00001 · Cited by 4
Tumor Cell Development: A Role for Viruses and Telomerase Activity?
Activity, T. (2014) · Advances in Tumor Virology · doi:10.4137/atv.s12440 · Cited by 4
Georgakopoulos, G., Tsiambas, E., Korkolopoulos, P., Korkolopoulou, P., Kavantzas, N., Karameris, A., Ragkos, V., Rigopoulos, D. N., Vilaras, G., Patsouris, E., et al. (2013) · PubMed · Cited by 4
Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter
Zou, L. (2010) · Oncology Reports · doi:10.3892/or_00000765 · Cited by 4
RLIM suppresses hepatocellular carcinogenesis by up-regulating p15 and p21
Huang, Y., Nie, M., Li, C., Zhao, Y., Li, J., Zhou, L., & Wang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.20904 · Cited by 4
Selective Recognition of Quadruplex DNA by Small Molecules
White, E. W. (2006) · Digital Archive @ GSU · doi:10.57709/1059253 · Cited by 5
Genes responsible for cancer: a review
Pawaiya, R. S., Krishna, L., & Kumar, R. (2011) · The Indian Journal of Animal Sciences · doi:10.56093/ijans.v81i8.4532 · Cited by 6
Hájek, M., Cvilink, V., Votruba, I., Holý, A., & Mertlíková‐Kaiserová, H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.006 · Cited by 3
Télomères et télomérase comme cibles thérapeutiques dans le traitement du cancer
Souiden, Y., Bouraoui, A., Chaieb, K., & Mahdouani, K. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1155 · Cited by 4
Meriranta, L., Pitkänen, E., & Leppä, S. (2023) · Seminars in Hematology · doi:10.1053/j.seminhematol.2023.06.006 · Cited by 3
An Evidence-based Perspective of Angelica Sinensis (Chinese Angelica) for Cancer Patients
Lin, P., Chiou, T., & Harn, H. (2011) · Evidence-based anticancer complementary and alternative medicine · doi:10.1007/978-94-007-0526-5_7 · Cited by 3
Inai, M., Kano, M., Shimada, Y., Sakurai, T., Chiba, T., & Imamura, M. (2001) · British Journal of Cancer · doi:10.1038/sj.bjc.6692032 · Cited by 3
Kim, H.-S., & Hong, J.-S. (2014) · Animal Cells and Systems · doi:10.1080/19768354.2014.987815 · Cited by 3
Cancer RNome: Evolution and Sustenance
Arora, M., & Kaul, D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1568-8_3 · Cited by 4
Molecular genetics of acute lymphoblastic leukemia
Mullighan, C. G. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.008 · Cited by 4
MYC: Master Regulator of Cell Death and Tumor Progression
Capasso, L., Mele, D., Fayyaz, F., Altucci, L., & Nebbioso, A. (2025) · Biochemistry · doi:10.5772/intechopen.1008763 · Cited by 2
Tara, S. A., Zekri, A., Sotoodehnejadnematalahi, F., & Modarressi, M. H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118509 · Cited by 2
Azlan, A., Rajasegaran, Y., Rosli, A. A., Saleem, M. T. S., Yusoff, N. M., Yik, M. Y., & Moses, E. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-18456-2 · Cited by 2
Designer Frankenproteins That Halt the Proliferation of Myc-Driven Cancer Cells
Ali, M. A., Akel, R., He, F., Piquette‐Miller, M., & Shin, J. A. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01493 · Cited by 2
Fujiwara, T., Urata, Y., & Tanaka, N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_13 · Cited by 3
Regulation of Telomerase Through Transcriptional and Posttranslational Mechanisms
Depcrynski, A., Sachs, P. C., Elmore, L. W., & Holt, S. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_3 · Cited by 2
Growth Factor Signaling Pathways in Cancer
Kalderon, D. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_9 · Cited by 2
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_4 · Cited by 4
Genomic Instability and Breast Cancer Progression.
Ingvarsson, S. (2006) · PubMed · Cited by 4
Cancer telomeres and white crows.
Meeker, A. K. (2018) · Europe PMC (PubMed Central) · Cited by 2
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Iguchi‐Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)80443-x · Cited by 2
Sample, J. T., & Ruf, I. K. (2006) · Infectious disease and therapy · doi:10.3109/9781420014280.010 · Cited by 2
Strategies for immortalisation of amnion‐derived mesenchymal and epithelial cells
Ansari, A., Denton, K. M., & Lim, R. (2022) · Cell Biology International · doi:10.1002/cbin.11892 · Cited by 2
Pathomechanisms of Endogenously Aged Skin
Makrantonaki, E., & Zouboulis, C. C. (2016) · Springer eBooks · doi:10.1007/978-3-662-47398-6_9 · Cited by 2
Telomerase and Malignant Transformation
Yu, J., & Dubeau, L. (2002) · Springer eBooks · doi:10.1007/978-1-4757-3587-1_9 · Cited by 2
Chau, N. P., Deschatrette, J., & Wolfrom, C. M. (2005) · PubMed · Cited by 2
Sojoudi, K., Azizi, H., & Skutella, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1426870/v1 · Cited by 2
Kotian, S., Rizzardi, L. F., & Stern, J. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.16.613267 · Cited by 2
Essential genes are dominantly activated by single transcription factorsPreprint
Capriati, M., Nestmann, S., Akan, I. S., Tuschmann, F., Druffel‐Augustin, S., & Grand, R. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.27.721063 · Cited by 2
Chronic sublethal exposure to methylmercury lengthens telomeres in developing zebra finches
Davis, R. L., Mason, S. D., Wake, C., Fabozzi, G., Catalano, W. L., Schramm, C. A., Henry, A. R., Parker, C. L., Laboune, F., McLaughlin, C. L., et al. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.127148 · Cited by 1
Babu, V. S., Ghosh, S., Bammidi, S., Jiwon, R., Sharma, R., Meyer, D., Hose, S., Pattabiraman, P. P., Sahel, J., Kidley, N. J., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2750048 · Cited by 1
Park, J. H., Lee, J. C., Sharma, S., Jiang, C., Lee, H., Park, H., & Kim, H. S. (2026) · MedComm · doi:10.1002/mco2.70630 · Cited by 1
Understanding the Role of p ‐Coumaric Acid in Diabetes and Cardiovascular Complications
Mishra, R., Gupta, S., Gaur, P. K., Lal, N., Lata, K., & Yadav, A. (2026) · ChemistrySelect · doi:10.1002/slct.73556 · Cited by 1
Chromosomal Translocations in B-Cell Leukemias and Lymphomas
Look, A. T., & Ferrando, A. A. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50024-1 · Cited by 2
Teralı, K., & Yılmazer, A. (2016) · InTech eBooks · doi:10.5772/65762 · Cited by 1
Khattar, E., & Tergaonkar, V. (2016) · InTech eBooks · doi:10.5772/62130 · Cited by 1
Mr, L., Lozynskyy, Y. S., Pławski, A., Pinyazhko, R., Prokopchuk, N. M., & Fedota, O. (2017) · Biopolymers and Cell · doi:10.7124/bc.000948 · Cited by 1
Telomerase and Its Therapeutic Implications in Cancer
Kumar, R., Gupta, N., & Sharma, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-4752-9_14 · Cited by 1
Jiang, F. (2004) · Digital Commons - University of South Florida (University of South Florida) · Cited by 3
Hahn, W. C. (2003) · Cancer Research and Treatment · doi:10.4143/crt.2003.35.6.467 · Cited by 1
Myc Oncoproteins as Targets for Therapeutic Intervention in Tumorigenesis
Berwanger, B., & Eilers, M. (2002) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-59259-153-4_2 · Cited by 1
Lee, C. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1920-8 · Cited by 1
Telomerase Activity in Human Umbilical Cord Cell Populations Containing Hematopoietic Stem Cells
Murthy, V. (2002) · Digital WPI · Cited by 1
The role of telomere maintenance in urological malignancies
Leao, R. R. N. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_4 · Cited by 1
Liu, Y. (2007) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/rtd-180813-15712
Inhibition of telomerase and hypoxia-inducible factor-1 in human glioblastoma multiforme
Mongiardi, M. (2009) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.58015/mongiardi-maria-patrizia_phd2009-08-05 · Cited by 1
Gene Therapy Targeting Receptor-Mediated Cell Death to Cancers
Zhang, L., & Fang, B. (2005) · Humana Press eBooks · doi:10.1385/1-59259-851-x:339
Liu, X., Li, X., Peng, Y., Ng, S. S., Yao, H., Wang, Z.-F., Wang, X., Kung, H., & Lin, M. C. M. (2012) · 癌症:英文版 · doi:10.5732/cjc.011.10378
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.